A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") Dysfunction

Plain-language summary

This study investigates the underlying biochemical pathways involved in Parkinson's disease (PD), in particular dysfunction of the mitochondria, the cell's energy-producing 'powerhouses'. People aged 18 and older who have Parkinson's disease or a related condition (such as Parkinson's plus, dystonia or tremor), or who join as healthy controls, may take part. It was run as a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

University College, London

Start date

8/18/2017

Estimated completion

4/1/2020

Countries

United Kingdom

Related genes

Locations

• London, United Kingdom

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

1. Diagnosed with PD, or a related condition (e.g. Parkinson's plus, dystonia, tremor) or healthy control participant
2. Age 18 years or over

Exclusion Criteria:

1\. Lack of capacity to consent to participate in the project